Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Syncytial Virus, Human | 24 | 2024 | 204 | 4.300 |
Why?
|
| Respiratory Syncytial Virus Infections | 27 | 2024 | 334 | 4.210 |
Why?
|
| Viral Load | 9 | 2025 | 384 | 1.980 |
Why?
|
| RNA, Viral | 8 | 2024 | 540 | 0.930 |
Why?
|
| Nasal Mucosa | 1 | 2024 | 65 | 0.930 |
Why?
|
| Viral Fusion Proteins | 9 | 2023 | 77 | 0.850 |
Why?
|
| Organoids | 2 | 2024 | 275 | 0.820 |
Why?
|
| Bacterial Adhesion | 3 | 2007 | 108 | 0.780 |
Why?
|
| Antibodies, Viral | 13 | 2023 | 1138 | 0.770 |
Why?
|
| Respiratory Tract Infections | 5 | 2022 | 263 | 0.740 |
Why?
|
| Respiratory Syncytial Viruses | 4 | 2024 | 145 | 0.730 |
Why?
|
| Transplant Recipients | 3 | 2021 | 210 | 0.730 |
Why?
|
| Virus Replication | 5 | 2024 | 603 | 0.700 |
Why?
|
| Respiratory Mucosa | 3 | 2020 | 91 | 0.660 |
Why?
|
| Cytokines | 2 | 2024 | 1288 | 0.650 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 5 | 2024 | 60 | 0.650 |
Why?
|
| Haemophilus influenzae | 4 | 2007 | 130 | 0.650 |
Why?
|
| Influenza, Human | 7 | 2024 | 646 | 0.600 |
Why?
|
| Bronchiolitis | 4 | 2021 | 119 | 0.550 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 5 | 2021 | 1192 | 0.550 |
Why?
|
| Picornaviridae Infections | 3 | 2024 | 48 | 0.530 |
Why?
|
| Virus Diseases | 4 | 2022 | 280 | 0.520 |
Why?
|
| Host-Pathogen Interactions | 3 | 2025 | 252 | 0.520 |
Why?
|
| Epithelial Cells | 4 | 2024 | 907 | 0.460 |
Why?
|
| Hospitalization | 8 | 2024 | 1727 | 0.440 |
Why?
|
| Enterovirus Infections | 2 | 2024 | 42 | 0.400 |
Why?
|
| Antibodies, Neutralizing | 7 | 2023 | 459 | 0.390 |
Why?
|
| Viruses | 3 | 2024 | 123 | 0.380 |
Why?
|
| Phenotype | 1 | 2021 | 4218 | 0.380 |
Why?
|
| Immunity, Innate | 3 | 2024 | 375 | 0.380 |
Why?
|
| Seasons | 5 | 2024 | 300 | 0.370 |
Why?
|
| Influenza A virus | 2 | 2015 | 134 | 0.360 |
Why?
|
| Humans | 58 | 2025 | 122423 | 0.360 |
Why?
|
| Immunity, Humoral | 2 | 2021 | 69 | 0.360 |
Why?
|
| Molecular Diagnostic Techniques | 3 | 2022 | 148 | 0.340 |
Why?
|
| Sindbis Virus | 1 | 2009 | 9 | 0.340 |
Why?
|
| Adult | 17 | 2025 | 28746 | 0.320 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2021 | 516 | 0.320 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2006 | 133 | 0.320 |
Why?
|
| Virus Shedding | 4 | 2021 | 80 | 0.310 |
Why?
|
| Infant | 16 | 2024 | 12347 | 0.300 |
Why?
|
| Streptococcus pneumoniae | 2 | 2007 | 371 | 0.300 |
Why?
|
| Genome, Viral | 3 | 2024 | 171 | 0.290 |
Why?
|
| Drosophila Proteins | 2 | 2013 | 709 | 0.290 |
Why?
|
| Genotype | 6 | 2021 | 2534 | 0.280 |
Why?
|
| Parainfluenza Virus 3, Human | 1 | 2006 | 12 | 0.260 |
Why?
|
| Female | 23 | 2025 | 64961 | 0.250 |
Why?
|
| Influenza Vaccines | 2 | 2023 | 469 | 0.240 |
Why?
|
| Texas | 5 | 2023 | 3513 | 0.240 |
Why?
|
| Male | 20 | 2025 | 59600 | 0.240 |
Why?
|
| Antigens, Viral | 3 | 2024 | 441 | 0.230 |
Why?
|
| Immunoglobulin A | 2 | 2021 | 198 | 0.230 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2024 | 14 | 0.230 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 772 | 0.230 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2024 | 61 | 0.230 |
Why?
|
| Acetamides | 1 | 2024 | 49 | 0.220 |
Why?
|
| Pandemics | 6 | 2024 | 1103 | 0.220 |
Why?
|
| Enterovirus | 1 | 2024 | 48 | 0.220 |
Why?
|
| Poliovirus | 1 | 2023 | 47 | 0.220 |
Why?
|
| Disease Outbreaks | 2 | 2023 | 319 | 0.220 |
Why?
|
| Up-Regulation | 1 | 2006 | 872 | 0.210 |
Why?
|
| Disease Susceptibility | 1 | 2024 | 298 | 0.210 |
Why?
|
| Cell Line | 5 | 2023 | 2786 | 0.200 |
Why?
|
| Coinfection | 2 | 2021 | 171 | 0.200 |
Why?
|
| Enterovirus D, Human | 1 | 2021 | 8 | 0.200 |
Why?
|
| Palivizumab | 2 | 2021 | 46 | 0.200 |
Why?
|
| Respiratory Tract Diseases | 1 | 2022 | 77 | 0.190 |
Why?
|
| Viral Structural Proteins | 1 | 2021 | 48 | 0.190 |
Why?
|
| Immunity, Mucosal | 1 | 2021 | 83 | 0.190 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1280 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 3 | 2024 | 1759 | 0.180 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 37 | 0.180 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 326 | 0.180 |
Why?
|
| Respiratory Sounds | 1 | 2021 | 68 | 0.180 |
Why?
|
| Rhinovirus | 2 | 2021 | 59 | 0.170 |
Why?
|
| Lung | 2 | 2025 | 1487 | 0.170 |
Why?
|
| Haemophilus | 1 | 2019 | 13 | 0.170 |
Why?
|
| Population Surveillance | 1 | 2021 | 382 | 0.160 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 151 | 0.160 |
Why?
|
| Phylogeny | 4 | 2024 | 684 | 0.160 |
Why?
|
| Cities | 3 | 2024 | 47 | 0.160 |
Why?
|
| Orthomyxoviridae | 1 | 2019 | 50 | 0.160 |
Why?
|
| Young Adult | 5 | 2021 | 8805 | 0.150 |
Why?
|
| Prospective Studies | 7 | 2024 | 5974 | 0.150 |
Why?
|
| Laboratories | 1 | 2019 | 83 | 0.150 |
Why?
|
| Child, Preschool | 10 | 2024 | 13840 | 0.150 |
Why?
|
| Cross Infection | 1 | 2021 | 331 | 0.140 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2019 | 441 | 0.140 |
Why?
|
| Pregnancy Complications | 1 | 2022 | 503 | 0.140 |
Why?
|
| Genes, Viral | 1 | 2017 | 186 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 289 | 0.140 |
Why?
|
| Child | 12 | 2024 | 24118 | 0.140 |
Why?
|
| CHO Cells | 2 | 2007 | 159 | 0.140 |
Why?
|
| Cricetinae | 2 | 2007 | 411 | 0.130 |
Why?
|
| Bacterial Infections | 1 | 2019 | 304 | 0.130 |
Why?
|
| Adolescent | 7 | 2024 | 18984 | 0.130 |
Why?
|
| Vaccination | 2 | 2023 | 946 | 0.120 |
Why?
|
| Influenza B virus | 1 | 2015 | 88 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 361 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 378 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2020 | 2833 | 0.120 |
Why?
|
| Mutation | 2 | 2024 | 5786 | 0.120 |
Why?
|
| Bodily Secretions | 1 | 2014 | 7 | 0.120 |
Why?
|
| Aged | 5 | 2021 | 18781 | 0.120 |
Why?
|
| Nasopharynx | 3 | 2019 | 80 | 0.120 |
Why?
|
| Middle Aged | 6 | 2022 | 25591 | 0.120 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 1703 | 0.120 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2014 | 62 | 0.120 |
Why?
|
| Microbiota | 1 | 2019 | 392 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2016 | 178 | 0.110 |
Why?
|
| Amino Acid Sequence | 2 | 2017 | 2701 | 0.110 |
Why?
|
| Caspases | 1 | 2014 | 160 | 0.110 |
Why?
|
| Infant, Newborn | 6 | 2024 | 8113 | 0.110 |
Why?
|
| Alphavirus | 1 | 2013 | 17 | 0.110 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2013 | 33 | 0.110 |
Why?
|
| Sequence Alignment | 1 | 2014 | 623 | 0.110 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 6303 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2014 | 300 | 0.100 |
Why?
|
| Cattle | 2 | 2024 | 559 | 0.100 |
Why?
|
| Epidemiological Monitoring | 2 | 2024 | 59 | 0.100 |
Why?
|
| Antibody Formation | 2 | 2021 | 256 | 0.090 |
Why?
|
| Animals | 7 | 2024 | 33897 | 0.090 |
Why?
|
| Insect Viruses | 1 | 2009 | 9 | 0.090 |
Why?
|
| Organisms, Genetically Modified | 1 | 2009 | 11 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 3 | 2015 | 1593 | 0.080 |
Why?
|
| Disease Vectors | 1 | 2009 | 24 | 0.080 |
Why?
|
| Haemophilus Infections | 2 | 2007 | 92 | 0.080 |
Why?
|
| United States | 5 | 2024 | 10478 | 0.080 |
Why?
|
| Genetic Variation | 3 | 2021 | 1476 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 3306 | 0.080 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 3888 | 0.080 |
Why?
|
| Molecular Typing | 2 | 2021 | 33 | 0.080 |
Why?
|
| Bacterial Outer Membrane Proteins | 2 | 2006 | 107 | 0.080 |
Why?
|
| Drosophila | 1 | 2013 | 766 | 0.080 |
Why?
|
| Virulence | 2 | 2006 | 259 | 0.080 |
Why?
|
| Cricetulus | 1 | 2007 | 100 | 0.070 |
Why?
|
| Islam | 1 | 2006 | 11 | 0.070 |
Why?
|
| Arabs | 1 | 2006 | 28 | 0.070 |
Why?
|
| Chromosomes, Human, Y | 1 | 2006 | 46 | 0.070 |
Why?
|
| Blotting, Western | 2 | 2006 | 1106 | 0.070 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2006 | 31 | 0.070 |
Why?
|
| Mucins | 1 | 2006 | 74 | 0.060 |
Why?
|
| Protein Conformation | 2 | 2018 | 835 | 0.060 |
Why?
|
| Pneumococcal Infections | 1 | 2007 | 274 | 0.060 |
Why?
|
| Antiviral Agents | 2 | 2022 | 736 | 0.060 |
Why?
|
| Livestock | 1 | 2024 | 12 | 0.060 |
Why?
|
| Farmers | 1 | 2024 | 12 | 0.060 |
Why?
|
| Haplotypes | 1 | 2006 | 513 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2006 | 226 | 0.060 |
Why?
|
| Influenza in Birds | 1 | 2024 | 27 | 0.060 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 57 | 0.060 |
Why?
|
| Birds | 1 | 2024 | 85 | 0.060 |
Why?
|
| Drosophila melanogaster | 1 | 2009 | 737 | 0.060 |
Why?
|
| Epoxy Compounds | 1 | 2024 | 18 | 0.060 |
Why?
|
| Mutation Rate | 1 | 2024 | 66 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2006 | 421 | 0.060 |
Why?
|
| Transfection | 1 | 2006 | 1076 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2006 | 287 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2006 | 810 | 0.050 |
Why?
|
| Protein Binding | 1 | 2007 | 1739 | 0.050 |
Why?
|
| Bacterial Capsules | 1 | 2003 | 37 | 0.050 |
Why?
|
| Pregnancy | 3 | 2022 | 7102 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2024 | 357 | 0.050 |
Why?
|
| Adhesins, Bacterial | 1 | 2003 | 75 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2023 | 3231 | 0.050 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2022 | 29 | 0.050 |
Why?
|
| Coronavirus | 1 | 2022 | 24 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 2012 | 0.050 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2023 | 118 | 0.050 |
Why?
|
| Paramyxoviridae Infections | 1 | 2022 | 44 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2023 | 125 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2003 | 175 | 0.050 |
Why?
|
| A549 Cells | 1 | 2022 | 45 | 0.050 |
Why?
|
| Sequence Analysis | 1 | 2021 | 55 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2024 | 382 | 0.050 |
Why?
|
| Turbinates | 1 | 2021 | 12 | 0.050 |
Why?
|
| Water | 1 | 2023 | 180 | 0.050 |
Why?
|
| Peripartum Period | 1 | 2022 | 31 | 0.050 |
Why?
|
| Immune Evasion | 1 | 2021 | 35 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 1 | 2024 | 371 | 0.050 |
Why?
|
| Fever | 1 | 2024 | 295 | 0.050 |
Why?
|
| Species Specificity | 1 | 2022 | 552 | 0.050 |
Why?
|
| Gene Expression | 1 | 2006 | 1592 | 0.050 |
Why?
|
| Open Reading Frames | 1 | 2021 | 212 | 0.050 |
Why?
|
| Public Health | 1 | 2023 | 253 | 0.050 |
Why?
|
| Molecular Epidemiology | 1 | 2021 | 156 | 0.050 |
Why?
|
| Reproducibility of Results | 2 | 2019 | 2794 | 0.050 |
Why?
|
| Pregnant Women | 1 | 2022 | 148 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2021 | 465 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2024 | 670 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2022 | 2814 | 0.040 |
Why?
|
| Immunoglobulin Idiotypes | 1 | 2020 | 11 | 0.040 |
Why?
|
| Antibody Affinity | 1 | 2020 | 41 | 0.040 |
Why?
|
| Sigmodontinae | 1 | 2020 | 42 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 3076 | 0.040 |
Why?
|
| Half-Life | 1 | 2020 | 157 | 0.040 |
Why?
|
| Adenosine Monophosphate | 1 | 2020 | 43 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2021 | 707 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 143 | 0.040 |
Why?
|
| Outpatients | 1 | 2021 | 254 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 6176 | 0.040 |
Why?
|
| Alanine | 1 | 2020 | 181 | 0.040 |
Why?
|
| DNA Probes | 1 | 2019 | 125 | 0.040 |
Why?
|
| RNA Stability | 1 | 2020 | 85 | 0.040 |
Why?
|
| Limit of Detection | 1 | 2019 | 59 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 745 | 0.040 |
Why?
|
| Hospitals, Pediatric | 1 | 2024 | 779 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 1317 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2006 | 3300 | 0.040 |
Why?
|
| Allografts | 1 | 2019 | 186 | 0.040 |
Why?
|
| Peptides | 1 | 2021 | 801 | 0.040 |
Why?
|
| DNA Primers | 1 | 2019 | 669 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 1301 | 0.040 |
Why?
|
| Chile | 1 | 2017 | 21 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2021 | 1293 | 0.040 |
Why?
|
| Antigenic Variation | 1 | 2017 | 39 | 0.040 |
Why?
|
| Recurrence | 1 | 2021 | 1412 | 0.030 |
Why?
|
| Child, Hospitalized | 1 | 2017 | 73 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2017 | 93 | 0.030 |
Why?
|
| Prenatal Care | 1 | 2019 | 340 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 390 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 233 | 0.030 |
Why?
|
| Nasal Cavity | 1 | 2015 | 47 | 0.030 |
Why?
|
| Bacteria | 1 | 2019 | 483 | 0.030 |
Why?
|
| Vaccines, Inactivated | 1 | 2016 | 144 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2015 | 137 | 0.030 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 592 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 4649 | 0.030 |
Why?
|
| Incidence | 1 | 2021 | 3008 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2013 | 231 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2018 | 1022 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 3306 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 1060 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2078 | 0.020 |
Why?
|
| Age Factors | 1 | 2015 | 2782 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 3613 | 0.020 |
Why?
|
| Geography | 1 | 2006 | 112 | 0.020 |
Why?
|
| Asia | 1 | 2006 | 105 | 0.020 |
Why?
|
| India | 1 | 2006 | 218 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1674 | 0.020 |
Why?
|
| Microsatellite Repeats | 1 | 2006 | 218 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2006 | 185 | 0.020 |
Why?
|
| Biomarkers | 1 | 2014 | 2942 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 4492 | 0.020 |
Why?
|
| Fimbriae Proteins | 1 | 2003 | 20 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2003 | 217 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 9871 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2006 | 1403 | 0.010 |
Why?
|
| Molecular Chaperones | 1 | 2003 | 169 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2003 | 481 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2019 | 15879 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 876 | 0.010 |
Why?
|
| Prevalence | 1 | 2003 | 2371 | 0.010 |
Why?
|